Ginkgo Bioworks Holdings, Inc. (DNA)
NYSE: DNA · Real-Time Price · USD
7.40
+0.44 (6.32%)
At close: Aug 21, 2026, 4:00 PM EDT
7.47
+0.07 (0.95%)
After-hours: Aug 21, 2026, 7:48 PM EDT
Ginkgo Bioworks Holdings Market Cap
Ginkgo Bioworks Holdings has a market cap or net worth of $498.32 million as of August 21, 2026. Its market cap has decreased by -22.43% in one year.
Market Cap
498.32M
Enterprise Value
600.27M
1-Year Change
-22.43%
Ranking
Category
Stock Price
$7.40
ChartMarket Cap Chart
Since April 19, 2021, Ginkgo Bioworks Holdings's market cap has decreased from $2.18B to $498.32M, a decrease of -77.16%. That is a compound annual growth rate of -24.15%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 498.32M | 5.51% |
| Dec 31, 2025 | 472.31M | -9.39% |
| Dec 31, 2024 | 521.27M | -84.36% |
| Dec 29, 2023 | 3.33B | 16.75% |
| Dec 30, 2022 | 2.86B | -76.89% |
| Dec 31, 2021 | 12.35B | 466.18% |
| Apr 19, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kyverna Therapeutics | 520.72M |
| MapLight Therapeutics | 519.90M |
| Evommune | 508.82M |
| BlossomHill Therapeutics | 501.94M |
| Relmada Therapeutics | 493.88M |
| C4 Therapeutics | 492.10M |
| ProKidney | 486.74M |
| Prothena Corporation | 485.13M |